Stereoselective HPLC separation of alvimopan on cellulose‐based immobilized polysaccharide as a chiral stationary phase

Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal pha...

Full description

Saved in:
Bibliographic Details
Published inChirality (New York, N.Y.) Vol. 30; no. 8; pp. 982 - 987
Main Authors Dhekale, Nitin H., Gunjal, Dattatray B., Gore, Anil H., Komaravolu, Yagnakirankumar, Hima Bindu, K., Kolekar, Govind B.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.08.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min−1, injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient.
AbstractList Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min−1, injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient.
Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5-dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n-hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min , injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient.
Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min−1, injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient.
Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5-dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n-hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v/v), column oven temperature 30°C, flow rate 1.0 mL min-1 , injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient.
Abstract Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds. In this study, a novel, simple, and specific analytical method was proposed to ascertain the chiral purity of alvimopan (ALV). The normal phase HPLC method was developed based on cellulose tris (3,5‐dichlorophenylcarbamate) stationary phase. The separation of ALV isomers achieved by using column CHIRALPAK IC (250 × 4.6 mm, 5 μm), mobile phase n‐hexane: isopropyl alcohol: ethanol: diethylamine (650:200:150:5 v /v), column oven temperature 30°C, flow rate 1.0 mL min −1 , injection volume was 10 μL, chromatographic response monitored at 273 nm. The developed method was validated as per the ICH guidelines and found precise, accurate, and linear. The advantage of the method is a good separation of ALV isomers within 35 minutes of the analysis time. Therefore, this method is suitable for routine determination of chiral purity of ALV active pharmaceutical ingredient.
Author Komaravolu, Yagnakirankumar
Gunjal, Dattatray B.
Hima Bindu, K.
Gore, Anil H.
Kolekar, Govind B.
Dhekale, Nitin H.
Author_xml – sequence: 1
  givenname: Nitin H.
  orcidid: 0000-0003-3976-3307
  surname: Dhekale
  fullname: Dhekale, Nitin H.
  organization: Dr. Reddy's Laboratories Ltd. Hyderabad
– sequence: 2
  givenname: Dattatray B.
  surname: Gunjal
  fullname: Gunjal, Dattatray B.
  organization: Shivaji University
– sequence: 3
  givenname: Anil H.
  surname: Gore
  fullname: Gore, Anil H.
  organization: Rajarshi Chhatrapati Shahu College Kolhapur
– sequence: 4
  givenname: Yagnakirankumar
  orcidid: 0000-0002-8914-7265
  surname: Komaravolu
  fullname: Komaravolu, Yagnakirankumar
  organization: Dr. Reddy's Laboratories Ltd. Hyderabad
– sequence: 5
  givenname: K.
  surname: Hima Bindu
  fullname: Hima Bindu, K.
  organization: Dr. Reddy's Laboratories Ltd. Hyderabad
– sequence: 6
  givenname: Govind B.
  surname: Kolekar
  fullname: Kolekar, Govind B.
  email: gbkolekar@yahoo.co.in
  organization: Shivaji University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29782664$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1DAUhi1URKeFDQ-ALLFBSCnHjhMnSzQCptJIIC4Su8iXE40rJw520mpY8Qg8Y5-knk5hwYKVbek7n87v_4ycjGFEQp4zuGAA_I3ZuXjBeVO1j8iKVRyKuqy_n5AVNG1bAAh-Ss5SugKAti7FE3LKW9nwuhYrsv8yY8SQ0KOZ3TXSzaftmiacVFSzCyMNPVX-2g1hUvkxUoPeLz4P3P76rVVCS90wBO28-5nvU_D7pIzZqegsUpWooof1lKdpvhequKfTLg8-JY975RM-ezjPybf3776uN8X244fL9dttYcpKtkVTN0KDUcyyppIS61pZoa2Sfa9FpUuLIEzPwULfS0DBtLSMa1YaqFrgTXlOXh29Uww_FkxzN7h0SKFGDEvqeP4fKVopZUZf_oNehSWOebtMSV6CbAAy9fpImRhSith3U3RDztUx6A6FdIfE3X0hGX7xoFz0gPYv-qeBDLAjcOM87v-j6taby89H6R19Y5pk
CitedBy_id crossref_primary_10_1002_chir_23082
crossref_primary_10_1016_j_trac_2019_07_011
crossref_primary_10_1016_j_chroma_2021_461878
crossref_primary_10_1016_j_jpba_2018_12_035
crossref_primary_10_1002_chir_23050
Cites_doi 10.1097/MJT.0b013e31804c6f37
10.1016/j.jpba.2011.06.011
10.1016/0021-9673(94)00803-5
10.1016/S0021-9673(00)99941-2
10.1016/j.jpba.2012.10.017
10.1101/cshperspect.a002147
10.1016/0021-9673(94)80400-1
10.1016/j.chroma.2004.04.040
10.1097/01.sla.0000232538.72458.93
10.1021/jm00041a003
10.1017/CBO9780511535468
10.1016/S0002-9610(01)00784-X
10.1016/S0021-9673(00)93965-7
10.1111/j.1365-2982.2005.00640.x
10.1002/(SICI)1521-3773(19980504)37:8<1020::AID-ANIE1020>3.0.CO;2-5
10.1067/mcp.2001.112680
10.1016/j.aca.2005.06.044
10.1056/NEJMoa010564
ContentType Journal Article
Copyright 2018 Wiley Periodicals, Inc.
Copyright_xml – notice: 2018 Wiley Periodicals, Inc.
DBID NPM
AAYXX
CITATION
7QO
7QR
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1002/chir.22859
DatabaseName PubMed
CrossRef
Biotechnology Research Abstracts
Chemoreception Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
Biotechnology Research Abstracts
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Biotechnology Research Abstracts
PubMed

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1520-636X
EndPage 987
ExternalDocumentID 10_1002_chir_22859
29782664
CHIR22859
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
29B
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIJN
ABOCM
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AI.
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BTSUX
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M21
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RWK
RX1
RYL
SAMSI
SUPJJ
TUS
UB1
UPT
V2E
V8K
VH1
W8V
W99
WBFHL
WBKPD
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XV2
YCJ
ZZTAW
~02
~IA
~WT
NPM
AAYXX
CITATION
7QO
7QR
7U7
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c3579-8684b0ca1d18577e66ad4bda7ffb45b3de04cf20d0ff70e41b7d12b13c0590283
IEDL.DBID DR2
ISSN 0899-0042
IngestDate Sat Aug 17 03:48:56 EDT 2024
Thu Oct 10 15:57:16 EDT 2024
Fri Aug 23 03:56:07 EDT 2024
Sat Nov 02 12:17:07 EDT 2024
Sat Aug 24 00:59:15 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords alvimopan
method validation
method development
stereoselective
HPLC
Language English
License 2018 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3579-8684b0ca1d18577e66ad4bda7ffb45b3de04cf20d0ff70e41b7d12b13c0590283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3976-3307
0000-0002-8914-7265
PMID 29782664
PQID 2072307800
PQPubID 986330
PageCount 6
ParticipantIDs proquest_miscellaneous_2042749777
proquest_journals_2072307800
crossref_primary_10_1002_chir_22859
pubmed_primary_29782664
wiley_primary_10_1002_chir_22859_CHIR22859
PublicationCentury 2000
PublicationDate August 2018
PublicationDateYYYYMMDD 2018-08-01
PublicationDate_xml – month: 08
  year: 2018
  text: August 2018
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Chichester
PublicationTitle Chirality (New York, N.Y.)
PublicationTitleAlternate Chirality
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 1994; 685
1998; 37
2007; 245
1994; 666
2005; 550
2001; 182
1987; 411
2013; 74
2008
2008; 15
2004; 1041
1994; 37
2004
2011; 56
1975; 112
2002
2010; 2
2005; 17
2001; 13
2001; 69
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
Lough WJ (e_1_2_6_10_1) 2002
e_1_2_6_19_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_22_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 2
  start-page: a002147
  year: 2010
  article-title: The origin of biological homochirality
  publication-title: Cold Spring Harb Perspect Biol
– volume: 550
  start-page: 123
  year: 2005
  end-page: 129
  article-title: Development and validation of HPLC methods for enantioseparation of mirtazapine enantiomers at analytical and semipreparative scale using polysaccharide chiral stationary phases
  publication-title: Anal Chim Acta
– volume: 15
  start-page: 59
  year: 2008
  end-page: 65
  article-title: New therapies in the treatment of postoperative ileus after gastrointestinal surgery
  publication-title: Am J of Ther
– volume: 411
  start-page: 139
  year: 1987
  end-page: 151
  article-title: Resolution of enantiomeric aromatic alcohols on a cellulose tribenzoate high‐performance liquid chromatography chiral stationary phase: a proposed chiral recognition mechanism
  publication-title: J Chromatogr
– volume: 685
  start-page: 349
  year: 1994
  end-page: 355
  article-title: Direct enantiomeric separation of the four stereoisomers of nadolol using normal phase and reversal‐cease high performance liquid chromatography with Chiralpak AD
  publication-title: J Chromatogr
– volume: 1041
  start-page: 119
  year: 2004
  end-page: 133
  article-title: Definition and system implementation of strategies for method development of chiral separations in normal‐ or reversed‐phase liquid chromatography using polysaccharide‐based stationary phases
  publication-title: J of Chromatogr A
– volume: 112
  start-page: 37
  year: 1975
  end-page: 60
– volume: 666
  start-page: 403
  year: 1994
  end-page: 419
  article-title: Resolution by high‐performance liquid chromatography using polysaccharide carbamates and benzoates as chiral stationary phases
  publication-title: J Chrom A
– year: 2002
– year: 2008
– volume: 37
  start-page: 1020
  year: 1998
  article-title: Polysaccharide derivatives for chromatographic separation of enantiomers
  publication-title: Angew Chem Int Ed
– year: 2004
– volume: 56
  start-page: 521
  year: 2011
  end-page: 537
  article-title: Chiral separations in normal‐phase liquid chromatography: enantioselectivity of recently commercialized polysaccharide based selectors. Part II. Optimization of enantioselectivity
  publication-title: J Pharm Biomed Anal
– volume: 37
  start-page: 2262
  year: 1994
  end-page: 2265
  article-title: Discovery of a potent, peripherally selective trans‐3, 4‐Dimethyl‐4‐(3‐hydroxyphenyl) piperidine opioid antagonist for the treatment of gastrointestinal motility disorders
  publication-title: J of Medi Chem
– volume: 13
  start-page: 935
  year: 2001
  end-page: 940
  article-title: Selective postoperative inhibition of gastrointestinal opioid receptors
  publication-title: The New Eng J of Medicine
– volume: 245
  start-page: 355
  year: 2007
  end-page: 363
  article-title: Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies
  publication-title: Ann Surg
– volume: 17
  start-page: 157
  issue: 2
  year: 2005
  end-page: 165
  article-title: Alvimopan, a selective peripherally acting μ‐opioid antagonist
  publication-title: Neurogas Motility
– volume: 74
  start-page: 111
  year: 2013
  end-page: 116
  article-title: Fundamental study of enantioselective HPLC separation of tapentadol enantiomers using cellulose‐based chiral stationary phase in normal phase mode
  publication-title: J Phar Bio Ana
– volume: 182
  start-page: 27S
  issue: suppl
  year: 2001
  end-page: 38S
  article-title: Alvimopan (ADL 8‐2698) is a novel peripheral opioid antagonist
  publication-title: The American J of Surg
– volume: 69
  start-page: 66
  year: 2001
  end-page: 71
  article-title: Jr ADL 8‐2698, a trans‐3,4‐dimethyl‐4‐(3‐hydroxyphenyl) piperidine, prevents gastro‐intestinal effects of intravenous morphine without affecting analgesia
  publication-title: Clin Pharmacol Ther
– ident: e_1_2_6_8_1
  doi: 10.1097/MJT.0b013e31804c6f37
– ident: e_1_2_6_18_1
  doi: 10.1016/j.jpba.2011.06.011
– ident: e_1_2_6_14_1
  doi: 10.1016/0021-9673(94)00803-5
– ident: e_1_2_6_19_1
  doi: 10.1016/S0021-9673(00)99941-2
– ident: e_1_2_6_15_1
  doi: 10.1016/j.jpba.2012.10.017
– ident: e_1_2_6_12_1
  doi: 10.1101/cshperspect.a002147
– ident: e_1_2_6_20_1
  doi: 10.1016/0021-9673(94)80400-1
– volume-title: Chirality in Natural and Applied Science
  year: 2002
  ident: e_1_2_6_10_1
  contributor:
    fullname: Lough WJ
– ident: e_1_2_6_13_1
  doi: 10.1016/j.chroma.2004.04.040
– ident: e_1_2_6_9_1
  doi: 10.1097/01.sla.0000232538.72458.93
– ident: e_1_2_6_4_1
  doi: 10.1021/jm00041a003
– ident: e_1_2_6_11_1
  doi: 10.1017/CBO9780511535468
– ident: e_1_2_6_3_1
  doi: 10.1016/S0002-9610(01)00784-X
– ident: e_1_2_6_22_1
  doi: 10.1016/S0021-9673(00)93965-7
– ident: e_1_2_6_2_1
  doi: 10.1111/j.1365-2982.2005.00640.x
– ident: e_1_2_6_6_1
– ident: e_1_2_6_21_1
  doi: 10.1002/(SICI)1521-3773(19980504)37:8<1020::AID-ANIE1020>3.0.CO;2-5
– ident: e_1_2_6_5_1
  doi: 10.1067/mcp.2001.112680
– ident: e_1_2_6_16_1
  doi: 10.1016/j.aca.2005.06.044
– ident: e_1_2_6_17_1
– ident: e_1_2_6_7_1
  doi: 10.1056/NEJMoa010564
SSID ssj0009634
Score 2.2650042
Snippet Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the compounds....
Abstract Chiral separation by normal phase high performance liquid chromatography is one of the most powerful technique to quantify the chiral purity of the...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 982
SubjectTerms Alcohols
alvimopan
Cellulose
Ethanol
Flow rates
Flow velocity
High performance liquid chromatography
HPLC
Ions
Isomers
Isopropanol
Isopropyl alcohol
Liquid chromatography
method development
method validation
Polysaccharides
Purity
Separation
Stationary phase
stereoselective
Stereoselectivity
Title Stereoselective HPLC separation of alvimopan on cellulose‐based immobilized polysaccharide as a chiral stationary phase
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fchir.22859
https://www.ncbi.nlm.nih.gov/pubmed/29782664
https://www.proquest.com/docview/2072307800
https://search.proquest.com/docview/2042749777
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB5CLsmlzU9_tkmLQksPBW9sWbbWkEvYJGxKW0raQC7FaGSZLNnaS7wb2JzyCHnGPklH0nqXpFBobzKS0EgajT7JM58A3sVk8zJtogAlx0BkSgUYaTKGOiGwQHu-dkFhn7-kg3Px8SK5WIGDNhbG80MsLtzsynD22i5whc3-kjRUXw6vu9zyr5EBjmJp_bmOzpbcUaRZjjuqZ8PsSTUX3KR8f1n14W70B8R8iFjdlnPyFH60wnpPk6vudIJdffuIx_F_e7MBT-ZYlB165dmEFVNtwfZhRefwnzP2njnvUHftvgVr_fZluG2YfaPJMHXjntAha8kGXz_1WWM8jXhdsbpkanRDWkCmhtG3_TswHVGFX3f3dtss2JDU37rl3lJ6XI9mjdI2_mtYGKYappgVlERrvKMAdYuNL6niMzg_Of7eHwTzJxwCHScyC3ppT2CoVVRYzilp0lQVAgslyxJFgnFhQqFLHhZhWcrQiAhlEXGMYu15ZeLnsFrVlXkJjJCOSSVXWKISSKiOck2GWZolhDJQdOBtO5X52DN15J6TmedW6NyNbgd221nO56u1yXkorT88YecO7C2yaVDt8KjK1FNbRtABntCy7MALrx2LZjgdxQnokAgf3Bz_pf28Pzg9c6lX_1J4B9YJqfW85-EurE6up-Y1oaEJvnFa_xvYDwex
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB5BOZRLKS3QLQWMQByQsk0cJ94cq4UqhW2FSiv1FtmOo67YJqtmF2l74hF4Rp6kM_b-qCAhwc2RbflvZvzZGX8D8DZGm5cZGwVach2ITKlARwaNoUkQLOCeb9yjsOOTND8Xny6Si7lvDr2F8fwQyws30gxnr0nB6UJ6f8Uaai6H111OBGz34QHqe0yRGz6crtijULYce1SPHtqjcC7ZSfn-qu7d_egPkHkXs7pN5_CRj6zaOq5C8jX51p1OdNfc_Mbk-N_j2YSNORxlB15-HsM9W2_B9kGNR_GrGXvHnIOou3nfgvX-IjjcNsy-4nrYpnVRdNBgsvzLoM9a65nEm5o1FVOj7ygIaG0YftMPgukIK_z68ZN2zpINUQPIM_cG0-NmNGuVoSdgw9Iy1TLFqKPYtdb7CuC42PgSKz6B88OPZ_08mEdxCEycyCzopT2hQ6OikminpE1TVQpdKllVWiQ6Lm0oTMXDMqwqGVoRaVlGXEex8dQy8VNYq5va7gBDsGNTyZWutBIagR3m2kxnaZYg0NCiA28Wa1mMPVlH4WmZeUGdLtzsdmBvsczFXGHbgoeSXOIRPnfg9TIbJ5WmR9W2mVIZgWd4BMyyA8-8eCyb4XgaR6yDXXjvFvkv7Rf9_OjUpXb_pfArWM_PjgfF4Ojk83N4iMCt5x0R92Btcj21LxAcTfRLpwK3MlULyQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFD7ahsS4YewHKAxmBOJiUrrEceJG4mYqVB2MaRpM2g2K_BetoiTV0iJ1VzzCnnFPsmO7aTWQkLY7R7blY_v4-LNzzmeAdzHavEyZKJCcyoBlQgQyUmgMVYJgAfd85YLCvh6l_VP2-Sw5W4IPTSyM54eYX7jZleHstV3gI13sLUhD1fngok0t_9oyPGApQl8LiU4W5FGoWo48qmPj7FE35-SkdG9R9_Z29A_GvA1Z3Z7TW4MfjbTe1eRnezKWbXX5F5HjfbvzBB7PwCjZ99qzDkum3IDN_RIP4r-m5D1x7qHu3n0DVrvN03CbMP2Gs2Gq2r2hg-aS9I8Pu6Q2nke8KklVEDH8jWqAtobgt_09MBlihes_V3bf1GSA-m_9ci8xPaqG01ooGwA20IaImghiBUXRau8pgN0io3OsuAWnvU_fu_1g9oZDoOKEZ0En7TAZKhFpSzrFTZoKzaQWvCgkS2SsTchUQUMdFgUPDYsk1xGVUaw8sUz8FFbKqjTPgSDUMSmnQhZSMImwDnNNJrM0SxBmSNaCt81U5iNP1ZF7UmaaW6FzN7ot2G5mOZ8t1zqnIbcO8QieW_Bmno2DaodHlKaa2DIMT_AIl3kLnnntmDdD8SyOSAdF2HVz_J_2827_4MSlXtyl8A48PP7Yyw8Pjr68hEeI2jreC3EbVsYXE_MKkdFYvnYL4AYRogp4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stereoselective+HPLC+separation+of+alvimopan+on+cellulose-based+immobilized+polysaccharide+as+a+chiral+stationary+phase&rft.jtitle=Chirality+%28New+York%2C+N.Y.%29&rft.au=Dhekale%2C+Nitin+H&rft.au=Gunjal%2C+Dattatray+B&rft.au=Gore%2C+Anil+H&rft.au=Komaravolu%2C+Yagnakirankumar&rft.date=2018-08-01&rft.eissn=1520-636X&rft_id=info:doi/10.1002%2Fchir.22859&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-0042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-0042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-0042&client=summon